Skip to content
ADMETatlas
peptide evidence atlas
Home
About
Home

Browse

PeptidesProductsEvidenceContext signalsDescriptors

Developability

ProfileComparator

Resources

ManualExplanationsStatisticsDownloadLicenseAbout

Statistics

Data distribution across ADMETatlas

Sealed release totals and live diagnostic distributions for the atlas database.

On this page
  • Sealed release at a glance
  • Molecular composition
  • Formal ADMET distribution
  • Endpoint value distributions
  • Evidence assay context
  • Product context
  • Provenance & corroboration
  • Evidence & curation detail

Sealed release at a glance

These headline totals come only from the checksum-sealed release manifest used by the download files, paper, and overview artwork. The detailed charts below are live diagnostic views and state their own denominators; they do not redefine the citable release totals.

ADMETatlas V1.0 · ATLXV0000005 · snapshot 2026-08-11
Identity records
37,467
canonical identity records in the sealed release
Endpoint evidence
39,641
public measurements in the sealed release
Context signals
3,678
release-linked trial, label, identity, and review context
Measured endpoints
17
formal measured endpoint definitions
Product records
110
products in the sealed release
Source records
43,276
release-exported source and reference records

Molecular composition

Live diagnostic view of sequence length, residue makeup, and chemical topology in the current atlas database. These denominators may change after the sealed release and are not citable release totals.

Sequence length
n =18,191canonical-sequence backbones

Peptide length distribution

Residue counts for canonical standard amino-acid sequences. Cyclic peptides and other modified forms are summarized separately, below.

loading chart…
Residue makeup
n =477,442residues

Amino-acid composition

Residues tallied across all standard amino-acid sequences, colored by side-chain class.

loading chart…
Nonpolar / hydrophobicPolar, unchargedBasic (+)Acidic (−)
Chemical topology
n =40,948peptidoforms

Topology classes

Topology class summarizes sequence/form representation, not developability quality.

loading chart…
Topology assignment confidencen = 15,600
High5,692(36.5%)Medium9,908(63.5%)
Cyclic peptides
n =8,032cyclic peptides

Cyclic peptide monomer length

Monomer count for cyclic peptides, using the source's authoritative monomer length. A further 5,162 modified or text-encoded forms from other sources use heterogeneous residue notations and are not length-binned.

loading chart…

Formal ADMET distribution

Live diagnostic endpoint evidence grouped by the five formal ADMET modules used across the site. The sunburst shows module-to-endpoint hierarchy, while the ranking shows where current evidence volume is concentrated.

Module hierarchy
n =39,424measurements

ADMET module to endpoint

Outer slices are endpoints; inner slices are the five formal modules.

loading chart…
Exposure800Distribution11,168Stability1,585Persistence3,026Safety22,845
Endpoint ranking
n =17endpoints

Largest endpoint evidence sets

Top 12 of 17 formal endpoints by record count. Labels link to endpoint pages below.

loading chart…
Hemolysis percent observation
15,352 records
Permeability
8,881 records
Cytotoxicity percent observation
3,274 records
Half-life (PK)
2,807 records
Cytotoxicity metric
2,801 records
Blood-brain barrier (BBB)
1,990 records
Hemolysis metric
1,418 records
Serum/plasma stability
1,032 records
Protease stability
553 records
AUC
267 records

Endpoint value distributions

How the actual measured values are distributed for the highest-volume numeric endpoints. Each histogram is binned within a single coherent unit; endpoints whose values mix incomparable units are deliberately not shown here.

Distribution
n =8,880measurements

Permeability

Reported values in log permeability (source-reported). Shaded band marks High permeability ≥ −6.0.

loading chart…
Safety
n =15,352measurements

Hemolysis percent observation

Reported values in % hemolysis.

loading chart…
Safety
n =3,274measurements

Cytotoxicity percent observation

Reported values in % cytotoxicity.

loading chart…
Safety
n =2,105measurements

Cytotoxicity metric

Reported values in µM (log scale).

loading chart…
Safety
n =1,257measurements

Hemolysis metric

Reported values in µM (log scale).

loading chart…

Evidence assay context

The experimental conditions under which the endpoint evidence was measured, normalized to controlled scientific vocabularies. Each measurement is comparable only within a matching organism, biological matrix, and route — these distributions show the assay landscape behind the numbers. Counts cover measurements where the source recorded the field; bars omit measurements with no recorded value.

Assay organism
n =23,706measurements

Evidence by species

Organism (or organism-derived system) in which each endpoint measurement was made.

loading chart…
Biological matrix
n =26,782measurements

Evidence by matrix

The biological material the peptide was measured in (plasma, cell culture, tissue, buffer, …). Values are only comparable within the same matrix.

loading chart…
Route of administration
n =2,759measurements

Evidence by route

Administration route for in-vivo / dosing studies. 'Multiple routes' marks measurements that report more than one route.

loading chart…

Product context

How the marketed and tracked peptide products in the atlas are described, kept separate from endpoint evidence.

Product route
n =110products

Product route distribution

Routes are product descriptors and should not be interpreted as endpoint evidence.

loading chart…
Product priority
n =110products

Product record bands

Priority bands help orient flagship examples versus broader catalog records.

loading chart…

Provenance & corroboration

How traceable the evidence is by source type, and how broadly each endpoint is independently corroborated across distinct external datasets. Individual upstream database names are kept out of the charts and listed in references and downloads instead.

Provenance
n =43,276reference records

Evidence provenance by source type

Each reference carries one scientific source class. ADMETatlas standardizes curated datasets and directly-extracted primary literature into one comparable evidence model, so every value keeps a traceable origin.

loading chart…
Source coverage
n =17endpoints

Endpoints by dataset coverage

Bands group endpoints by how many distinct external datasets contain records for them. This describes source coverage, not concordance, independence, or evidence quality. The same primary study can appear through more than one dataset.

loading chart…
Endpoint corroboration

High-volume endpoint context

Hemolysis percent observationSafety2 datasets15,352PermeabilityDistribution2 datasets8,881Cytotoxicity percent observationSafety1 dataset3,274Half-life (PK)Persistence3 datasets2,807Cytotoxicity metricSafety2 datasets2,801Blood-brain barrier (BBB)Distribution2 datasets1,990Hemolysis metricSafety3 datasets1,418Serum/plasma stabilityStability2 datasets1,032

Evidence & curation detail

Curation mechanics behind the numbers: how measurements are classed by scientific role and value form, and how context signals attach. These support traceability and are collapsed by default to keep the page science-forward.

Show curation & evidence-shape charts▾
Evidence roles
n =17endpoints

Formal evidence and reported observations

Stacked bars show how each of the top 12 of 17 endpoints is composed.

loading chart…
Value forms
n =39,641measurements

How endpoint values are represented

Numeric values, ranges, categorical values, and text observations remain separate.

loading chart…
Signal types
n =3,678context signals

Context signals by type

Context signals support interpretation around trials, product identity, and reviews; they are not formal endpoint measurements.

loading chart…
Linked object
n =3,678context signals

Where context attaches

Signals attach at the product level, to the linked peptide identity, or — when identity is not yet resolved — to the source record alone.

loading chart…
ADMETatlas
peptide evidence atlas

ADMETatlas is an open, curated atlas of ADMET evidence for therapeutic peptides — spanning developability, membrane permeability and blood–brain-barrier transport, immune-recognition context, and approved-product context. Every measurement stays linked to its original source, with stable identifiers and transparent curation, so results can be traced, cited, and reproduced.

Browse
PeptidesProductsEvidenceContext signalsDescriptors
Resource
DevelopabilityComparatorManualExplanationsStatisticsDownloadAbout
Stack
  • RDKit
  • Mol*
  • Python
  • FastAPI
  • PostgreSQL
  • Next.js
  • React
  • TypeScript
  • Tailwind CSS
  • Apache ECharts
© 2026 ADMETatlas, an academic peptide ADMET evidence atlas.